Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: Driven to Diffraction—X-rays Show APP Dimerization
5 March 2010. There is more to amyloid precursor protein (APP) than the peptide for which it is named. At 40-42 amino acids, amyloid-β (Aβ) may attract the most attention, but the full protein is almost 20 times as large, with most of it protruding from the cell surface. While the extracellular expanse of APP may be its business end, relatively little is understood about what it does. Some evidence suggests that the protein forms dimers, which could be important for function, and a paper in this week’s PNAS supports that idea. Researchers led by Manuel Than at the Leibniz Institute for Age Research-Fritz Lipmann Institute, Jena, Germany, crystallized one part of the APP extracellular domain. Analysis of the crystal structure predicts that it, and by extrapolation APP itself, should form a dimer in the presence of heparin.

“It is now very probable that cellular signaling of APP indeed uses the well-established principle of receptor dimerization, and in the future, other biomolecules, in addition to heparin/heparan sulfate, may be found to influence the APP monomer/dimer equilibrium,” noted Mathias Gralle, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany, in an e-mail to ARF (see full comment below). Gralle was not involved in the work but has studied the three-dimensional structure of APP in solution (see Gralle et al., 2006).

Transmembrane proteins such as APP are notoriously difficult to crystallize. Researchers generally get around this by studying smaller pieces rather than the whole protein. First author Sven Dahms and colleagues focused on the E1 N-terminal region of APP comprising copper binding (CuBD) and growth factor-like domains (GFLDs). They obtained enough of the protein fragment for crystallization by expressing it in and purifying it from Escherichia coli. Analysis of the crystals showed that the two domains rigidly interact to form one folding unit (see image below). “The solved structure could have a strong impact on function, because it indicates the two domains cannot work independently,” Than told ARF. How function might be affected by this rigid structure remains to be seen.

3-D Structure of the E1 N-terminal Domain of APP
The CuBD (green) and the GFLD (blue) form distinct folds connected by an interdomain linker (red). Dark colors represent α helices and lighter colors β-sheets. Disulphide bonds are shown as gold spheres. Image credit: Manuel Than, Leibniz Institute for Age Research-Fritz Lipmann Institute

The analysis also indicates that two E1 fragments can come together to form a dimer in the presence of heparin, which is known to bind APP. The protein dimer interface comprises positively charged amino acid side chains that are held in place by the negatively charged heparin. This would likely affect the whole structure of APP because “if E1 comes together, then the whole molecule must come together,” said Than.

Interestingly, the researchers found that the stability of the rigid interdomain structure of the E1 monomer is pH dependent, being tighter at slightly acidic pH (~5.0). The researchers suggest that APP could form distinct conformations in different cellular and extracellular milieus.—Tom Fagan.

Reference:
Dahms SO, Hoefgen S, Roeser D, Schlott B, Guhrs K-H, Than ME. Structure and biochemical analysis of the heparin-induced E1-dimer of the amyloid precursor protein. PNAS 2010, March 1. Abstract

 
Comments on News and Primary Papers
  Comment by:  Matthias Gralle
Submitted 5 March 2010  |  Permalink Posted 5 March 2010

While there is a wealth of studies proposing different roles for APP in health and disease, mechanistic explanations for the functions of APP are still not as reliable as one would wish. Structural detail seems the way forward to sift through the proposed mechanisms and agree on the most plausible ones.

A few years ago, several fragments of APP were solved independently at atomic resolution, but it seemed impossible to get the same level of resolution for the full-length protein. This would be a serious problem for studying regulation and cooperation between its different binding partners. Now Dahms et al. prove that it is indeed possible to study the interactions between two domains of APP, the N-terminal growth factor-like domain and the copper-binding domain, and derive new mechanistical insight from this. This opens up the possibility of further progress towards a high-resolution understanding of full-length APP.

One major conclusion of Dahm et al. is that heparin indeed induces dimerization of their object of study, the two most N-terminal domains of...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad